哈普特蛋白表型和心血管风险:ACCORD血压RCT的同意
Samantha K Lavallée1,2,3, Allie S Carew1,2,3, Rachel A Warren1,3
1Department of Medicine (S.K.L., A.S.C., R.A.W., J.L,S., L.E.C.), Dalhousie University, Halifax, Nova Scotia, Canada.
Hypertension (Dallas, Tex. : 1979)
|November 11, 2025
概括
在2型糖尿病患者中,强化血压控制减少了具有Hp1等位基因但没有Hp2-2的心血管事件. 哈普特球蛋白表型可能解释心血管风险降低的不同治疗反应.
科学领域:
- 心血管医学 心血管医学
- 遗传学 是一个遗传学.
- 内分泌学 在内分泌学.
背景情况:
- 高血压是心血管疾病 (CVD),冠状动脉疾病 (CAD) 和2型糖尿病中风的已知危险因素.
- 之前对密集血压控制的试验在减少心血管事件方面产生了相互矛盾的结果.
- 球蛋白 (Hp) 现型可能是一个未测量的影响这些结果的生物学因素.
研究的目的:
- 为了研究密集的血压控制和心血管事件之间的关联,按Haptoglobin (Hp) 现型分层.
- 探索Hp表型是否影响密集血压管理在降低2型糖尿病心血管风险方面的有效性.
主要方法:
- 分析了来自ACCORD (控制糖尿病心血管风险的行动) 血压试验的数据.
- 使用多变量调整的考克斯比例危险回归模型.
- 分层分析比较Hp2-2表型和Hp1等位基因载体参与者的强化血压控制与标准血压控制.
主要成果:
- 强化血压治疗显著降低Hp1等位基载体 (HR,0.76) 的复合心血管疾病风险,但不是Hp2-2表型参与者 (HR,1.12).
- 在Hp1携带者 (HR,0.53) 进行密集治疗时,观察到中风风险显著降低,但在Hp2-2参与者中没有.
- 在密集治疗与标准治疗组之间,在CAD风险降低方面没有发现显著差异.
结论:
- 在ACCORD试验中观察到的对密集血压控制的可变反应,可能部分归因于平分球蛋白表型的差异.
- 需要进一步的研究和复制,以确认Hp表型在调节2型糖尿病心血管结果中的作用.
相关概念视频
Hypertension and Regulation of Blood Pressure
3.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
525
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
525
Hypertension II: Pathophysiology
765
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
765
Hypertension III: Clinical Manifestations and Diagnostic Studies
452
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
452
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
774
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
774
Hypertension IV: Drug Therapy and Lifestyle Modifications
600
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
600


